The available data on the Sinovac-CoronaVac (COVID-19) vaccine in pregnant women are insufficient to assess either vaccine efficacy or possible vaccine-associated risks in pregnancy. Should pregnant and breastfeeding women be vaccinated? But individuals may choose to delay vaccination for 3 months following the infection.
The Sinovac vaccine can be offered to people who have had COVID-19 in the past. In line with the WHO Prioritization Roadmap and the WHO Values Framework, older adults, health workers and immunocompromised persons should be prioritised. The vaccine is safe and effective for all individuals aged 18 and above. The WHO Strategic Advisory Group of Experts on Immunization (SAGE) has issued updated interim policy recommendations for the use of the Sinovac-CoronaVac vaccine against COVID-19. This article provides a summary of those interim recommendations you may access the full guidance document here. Updated on 10 June 2022 pursuant to revised interim recommendations.
0 kommentar(er)
